Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dis-Chem PharmaciesJSE:DCP -0.92%85 PB Ratio is 4.88 as of Jul. 18, 2026, which is 42% below its 10-year median of 8.44. GuruFocus rates JSE:DCP with a GF Score™ of 85/100 and a GF Value™ of R38.23 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 610 Healthcare Providers & Services companies, Dis-Chem Pharmacies ranks worse than 80.98% on this metric.
Dis-Chem Pharmacies Ltd stock PB Ratio (=4.94) is close to 10-year low of 4.61.
The historical rank and industry rank for Dis-Chem Pharmacies's PB Ratio or its related term are showing as below:
JSE:DCP'
s PB Ratio Range Over the Past 10 Years
Min: 4.61 Med: 8.44 Max: 44.64
Current: 4.87
During the past 13 years, Dis-Chem Pharmacies's highest PB Ratio was 44.64. The lowest was 4.61. And the median was 8.44.
JSE:DCP's PB Ratio is ranked worse than 80.98% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 2.025
vs JSE:DCP: 4.87
During the past 12 months, Dis-Chem Pharmacies's average Book Value Per Share Growth Rate was 8.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 13.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 14.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 21.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Dis-Chem Pharmacies was 37.70% per year. The lowest was 5.60% per year. And the median was 18.20% per year.
Back to Basics: PB Ratio
Dis-Chem Pharmacies (JSE:DCP) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Dis-Chem Pharmacies PB Ratio Related Terms
Dis-Chem Pharmacies PB Ratio Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies PB Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dis-Chem Pharmacies PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's PB Ratio distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Dis-Chem Pharmacies (JSE:DCP) has a PB Ratio of 4.88 as of Jul. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dis-Chem Pharmacies and its competitors. This is 42% below median its historical median of 8.44. Over the past decade, Dis-Chem Pharmacies' PB Ratio has ranged from 4.61 to 44.64. According to the industry distribution chart, Dis-Chem Pharmacies ranks #494 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 81%.
Is Dis-Chem Pharmacies' PB Ratio too high?
Dis-Chem Pharmacies' current PB Ratio of 4.88 is 42% below median its 10-year median of 8.44. Over the past 10 years, this metric has ranged from a low of 4.61 to a high of 44.64. The Healthcare Providers & Services industry median PB Ratio is 2.03. Dis-Chem Pharmacies' value of 4.88 is 141% above this industry median. Based on the distribution chart, Dis-Chem Pharmacies ranks #494 out of 610 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dis-Chem Pharmacies has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #494 out of 610 companies for PB Ratio. This places Dis-Chem Pharmacies in the lower half of its industry. The industry median PB Ratio is 2.03. Dis-Chem Pharmacies' value of 4.88 is 141% above this benchmark. Historically, Dis-Chem Pharmacies' own PB Ratio has ranged from 4.61 to 44.64 over the past decade. While the company's 10-year median is 8.44 vs. the industry median of 2.03, Dis-Chem Pharmacies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.03, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dis-Chem Pharmacies's current PB Ratio of 4.88 is 141% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current PB Ratio is 4.88, which is 42% below median its own 10-year median of 8.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.23, compared to a current price of R32.20 — trading 15.8% below its estimated fair value. The current PB Ratio is 4.88, which is 42% below median its 10-year median of 8.44 and 141% above the Healthcare Providers & Services industry median of 2.03. Dis-Chem Pharmacies' overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current PB Ratio is 4.88 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R32.20 is trading 15.8% below its estimated GF Value™ of R38.23.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
PB Ratio: 4.88 (42% below median its 10-year median of 8.44)
GF Value™: R38.23 vs. price of R32.20 (15.8% below fair value)
Industry Position: 141% above the Healthcare Providers & Services median (#494 of 610)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
85GF Score
Get the complete analysis for JSE:DCP
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
